دورية أكاديمية

Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial

التفاصيل البيبلوغرافية
العنوان: Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
المؤلفون: Mu, Yiming *, Bao, Xiaolei, Eliaschewitz, Freddy G, Hansen, Morten Rix, Kim, Bom Taeck, Koroleva, Anna, Ma, Ronald C W, Yang, Tao, Zu, Ning, Liu, Ming
المصدر: In The Lancet Diabetes & Endocrinology March 2024 12(3):184-195
قاعدة البيانات: ScienceDirect
الوصف
تدمد:22138587
DOI:10.1016/S2213-8587(23)00388-1